Trial Profile
Retrospective study of docetaxel treatment in patients with castration-resistant prostate cancer.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2015
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms CYCLOP study
- 04 Sep 2015 New trial record
- 01 Feb 2014 Interim results (N=128) presented at the 2014 Genitourinary Cancers Symposium.